Commentary: Systemic adjuvant therapy for esophageal adenocarcinoma
نویسندگان
چکیده
منابع مشابه
Current Therapy for Esophageal Adenocarcinoma
Esophageal adenocarcinoma (EAC) affects approximately 17,000 individuals per year in the United States, is increasing in incidence, and is associated with an exceptionally high mortality rate. 1, 2 Overall five-year survival despite aggressive treatment in large, multidisciplinary oncology centers ranges between 15 and 25%. Poor outcome in patients with EAC is reflective of both deficiencies in...
متن کاملCommentary (Kelsen): Adjuvant Therapy for Colorectal Cancer
As well-outlined by Drs. Beavan and Goldberg, in the past 20 years, the outlook for these patients has gone from pessimism that anything more than surgery was useful to certainty that we can markedly decrease the risk of recurrence. At least some steps have been made in clearly identifying which patients should receive adjuvant therapy. There is general agreement on current effective regimens, ...
متن کاملAdjuvant Therapy for Adenocarcinoma of the Pancreas
The delivery of postoperative combined modality adjuvant therapy for completely resected pancreatic cancer was initially shown to be beneficial on the basis of a prospective, randomized trial published in 1985. Since then, oncologists have debated whether chemotherapy, chemoradiation, or both is optimal adjuvant therapy after pancreatectomy for ductal adenocarcinoma of the pancreas; no global c...
متن کاملAdjuvant systemic therapy for breast cancer.
The first procedure in primary breast cancer is usually the surgical excision of the tumor. However, a medical therapy is necessary in almost all patients to treat the systemic component of the disease. Which medical approach is recommended depends on the biology of the tumor itself. Endocrine-responsive tumors must be treated by an endocrine therapy according to their menopausal status. In HER...
متن کاملGastric adenocarcinoma surgery and adjuvant therapy.
Gastric adenocarcinoma is one of the most common causes of death worldwide. Surgical resection remains the mainstay of therapy, offering the only chance for complete cure. Resection is based on the principles of obtaining adequate margins, with the extent of lymphadenectomy remaining controversial. Neoadjuvant and adjuvant therapies are used to reduce local recurrence and improve long-term surv...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JTCVS Open
سال: 2021
ISSN: 2666-2736
DOI: 10.1016/j.xjon.2021.01.002